Most neck treatments are bought for the wrong problem.

The neck's crepiness and red-brown mottling are largely photoaging — a review of mottled neck pigmentation names sun exposure as a well-known, important cause (neck pigmentation review), and poikiloderma of Civatte characteristically spares the shaded parts of the neck (50-patient clinical study) — and the one randomized trial of daily sunscreen against visible skin aging, in adults under 55, found daily users "showed no detectable increase in skin aging after 4.5 years" (Nambour trial). The neck was one of the sites participants covered every day (1999 trial report), but aging was graded from silicone impressions of the back of the hand (grading-method study), so the neck result is inferred, not measured. The practical failure is habit: sunscreen applications stop at the jawline — even photosensitive patients most often missed the back and sides of the neck, leaving a median of no sunscreen there (1999 application study). Extend every morning's SPF 30–50 down to the chest, and reapply on days the neckline is out. Every treatment below is undone without it — IPL results in particular recur with sun.

Tretinoin and retinol have decades of vehicle-controlled trials behind them for fine wrinkling and pigment — a 2025 meta-analysis pooled eight facial tretinoin trials (1,361 patients), tretinoin lightened liver spots on the arms and hands as well as on the face (1992 NEJM trial), and 0.4% retinol reduced fine wrinkles on the arm against its vehicle (2007 arm trial). Those results are the reason to use them on the neck, because no trial has tested a retinoid alone on the neck against its vehicle: one vehicle-controlled trial applied tretinoin 0.05% to face, neck and forearm together and reported significant overall improvement (1994 Australian trial), and a vehicle-controlled chest trial found tretinoin 0.05% lotion and its vehicle both 30–40% improved at six months (2022 chest trial). This tier is borrowed, and the evidence off the face is mixed. The practical difference is tolerance: thinner skin with fewer oil glands stings and flakes more. Start with 0.025% tretinoin or a retinaldehyde/retinol product two or three nights a week, buffer over moisturizer, and expect 4–6 months before texture changes. A ceramide-type moisturizer (see our ceramides guide) is the tolerance tool; SPF is non-negotiable.

A rare genuine trial of a home device: a multicenter, randomized, double-blind sham-controlled study of a Korean LED neck collar (9 minutes a day for 12 weeks, 70 participants). Blinded dermatologists rated 77% of the active group improved versus 9% on sham; the device also came with thyroid ultrasound monitoring that found no changes. The honest caveat is in the same paper: participants' own ratings did not separate active from sham — the improvement is real to a trained eye and instruments, subtle to the owner. Modest texture benefit; nothing for bands, fat, or laxity. (Dose and device honesty matter — see our red-light guide.)

Revision Nectifirm, SkinMedica Neck Correct, StriVectin and their peers sell on brand-run "clinical" results that are, on inspection, hydration effects: any good moisturizer plumps crepey skin for hours, and instrument readings improve accordingly. Most published neck-cream studies are single-arm and measured against baseline — in one 12-week open-label trial, 26 women improved 21% on lines and wrinkles (open-label trial) — and in the one vehicle-controlled neck trial we found, a hyaluronic acid, peptide and antioxidant serum-and-cream system tested against its own vehicles in 31 people, "Both active and placebo cream and serum showed improvement of wrinkles, laxity, pigmentation, erythema, dryness, and texture of the skin" (placebo-controlled trial). None contains anything a retinoid-plus-SPF routine lacks except a premium. If you enjoy one as your neck moisturizer, fine — but the €100 is better spent on tretinoin and sunscreen, and the evidence gradient here is steep.

Home radiofrequency wands (TriPollar-class) have manufacturer-run studies reporting mild facial tightening; a systematic review of home beauty devices finds few controlled trials of any class. Microcurrent produces a transient "toned" look with no durable structural data. On the neck specifically there is essentially nothing published. Pleasant rituals; not answers to a loose neck.

Side- and stomach-sleeping do compress the neck and cheek into folds — a 2016 review describes the compression, shear and stress forces that act on the face in lateral or prone sleep (sleep-wrinkle review) — but no trial shows a pillow prevents lines: the study behind one "anti-wrinkle" design pressed 15 faces against a clear air-filled pillow to document the folds and proposed a pressure-redistributing shape, without reporting whether it prevented any (pillow-design study). Silicone patches work by occlusion: the skin under them is hydrated on removal, briefly — in forearm tests the extra water began evaporating as soon as the sheet came off, and after seven days under silicone the outer layer was back to untreated hydration within the half-hour of measurement (silicone-sheet study). Harmless, cheap, temporary. Back-sleeping is free.

The one neck treatment with pivotal randomized data. Botulinum toxin relaxes the platysma cords, softening the vertical bands that stand out on animation and easing the muscle's downward pull on the jawline — the "Nefertiti lift". Two phase-3 placebo-controlled trials underpinned the 2024 FDA approval for platysma bands, with roughly four times the placebo responder rate at two weeks and no excess of dysphagia, voice change, or neck weakness at label doses (pooled analysis). Duration 3–4 months.

What it does not do: tighten loose skin or reduce fat. Risks scale with dose and depth — high doses (>50–75 U) or injection near the strap muscles can cause swallowing or voice problems; injectors with neck anatomy training only.

A synthetic bile acid injected into submental fat dissolves the fat cells permanently. The pivotal phase-3 program (two trials of ~500 patients each) showed roughly two-thirds of treated patients achieving at least a one-grade improvement on clinician and patient scales, with MRI-measured fat volume down ~40%. It is nationally authorised across the EU and the UK (prescription-only; supply varies by country).

Costs beyond the invoice: dramatic swelling for up to two weeks, numbness for longer, and temporary marginal mandibular nerve weakness (an asymmetric smile) in ~4%; skin ulceration if injected too superficially. The decisive candidacy rule: only where skin will retract — dissolving fat under a loose curtain leaves a looser curtain.

Horizontal neck lines are creases, and the best-supported fix is filling the crease: dilute or soft hyaluronic-acid gel placed intradermally along the line (Restylane Skinboosters/Vital, Volite-class products, or low-G′ fillers). A systematic review pooled eleven studies — one randomized — reporting roughly 1.4 grades of improvement on line scales, with about half of patients retreating within 12 months; a prospective series describes the technique. Superficial nodules and blue-grey Tyndall discoloration are the practical complications of thin neck skin — small volumes, correct plane, hyaluronidase on hand (see our filler guide).

Diluting CaHA 1:2 to 1:6 and fanning it under crepey neck skin is now a common "biostimulation" protocol; consensus papers and open-label series report improved laxity and texture scores over 12–18 months, and face biopsies show CaHA does build new collagen. What's missing on the neck is any comparison against sham or against hydration alone. Plausible, popular, unproven — and irreversible, unlike HA.

PLLA has a randomized pivotal trial for nasolabial folds and a reputation for global "skin quality"; on the neck the published record is a 36-patient neck-and-chest series with one early nodule (2009 series), a 2026 review of 24 neck-filler studies in 887 patients (2026 review) and expert technique papers, with the neck's thin skin raising nodule risk if dilution or massage is imperfect. Until a controlled trial reports, this stays a face-derived extrapolation with more downside than the CaHA protocol above.

The "bioremodelling" injectable is marketed hard for crepey necks on the strength of open-label, manufacturer-linked studies reporting laxity and hydration improvements — with bruising in around half of patients. The one randomized, triple-blind, saline-controlled trial (face) found dermal thickness rose on both the Profhilo and the placebo side. Expect a hydration glow with a strong placebo component; expect no lift.

Salmon-DNA "skin boosters" ride a European trend with a thin file: a 2025 systematic review found nine studies of low and moderate quality, 219 patients in all, and concluded that "Rigorous, high-quality studies are essential" (2025 systematic review), and nothing controlled on the neck — the only neck data we found are a real-life series in which clinicians rated over 93% of 33 treated necks moderately to significantly improved, with no comparison group (real-life series). CE-marked as devices (a low evidence bar; the product in that series is a class III device), not approved as medicines. Full grading lives in our regenerative-aesthetics guide; for the neck specifically, the tier is borrowed and downgraded.